The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Treatment outcomes for multidrug-resistant Mycobacterium Tuberculosis (MDRTB) are generally poor compared to drug sensitive disease. We sought to estimate treatment outcomes and identify risk factors associated with poor outcomes in patients with MDRTB. METHODOLOGY/PRINCIPAL FINDINGS: We performed a systematic search (to December 2008) to identify trials describing outcomes of patients treated for MDRTB. We pooled appropriate data to estimate WHO-defined outcomes at the end of treatment and follow-up. Where appropriate, pooled covariates were analyzed to identify factors associated with worse outcomes. Among articles identified, 36 met our inclusion criteria, representing 31 treatment programmes from 21 countries. In a pooled analysis, 62% [95% CI 57-67] of patients had successful outcomes, while 13% [9]-[17] defaulted, 11% [9]-[13] died, and 2% [1]-[4] were transferred out. Factors associated with worse outcome included male gender 0.61 (OR for successful outcome) [0.46-0.82], alcohol abuse 0.49 [0.39-0.63], low BMI 0.41[0.23-0.72], smear positivity at diagnosis 0.53 [0.31-0.91], fluoroquinolone resistance 0.45 [0.22-0.91] and the presence of an XDR resistance pattern 0.57 [0.41-0.80]. Factors associated with successful outcome were surgical intervention 1.91 [1.44-2.53], no previous treatment 1.42 [1.05-1.94], and fluoroquinolone use 2.20 [1.19-4.09]. CONCLUSIONS/SIGNIFICANCE: We have identified several factors associated with poor outcomes where interventions may be targeted. In addition, we have identified high rates of default, which likely contributes to the development and spread of MDRTB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Jeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Orenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis
Mitnick, C. D., Shin, S. S., Seung, K. J., Rich, M. L., Atwood, S. S., Furin, J. J., Fitzmaurice, G. M., Alcantara Viru, F. A., Appleton, S. C., Bayona, J. N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800106 · Cited by 402
Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis
Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., & Iseman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1159oc · Cited by 336
Programmes and principles in treatment of multidrug-resistant tuberculosis
Mukherjee, J. S., Rich, M. L., Socci, A. R., Joseph, J. K., Virú, F. A., Shin, S. S., Furin, J. J., Becerra, M. C., Barry, D. J., Kim, J. Y., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15496-2 · Cited by 333
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
Laserson, K. F., Thorpe, L. E., Leimane, V., Weyer, K., Mitnick, C. D., Riekstiņa, V., Zarovska, E., Rich, M., Fraser, H., Alarcon, E., et al. (2005) · PubMed · Cited by 292
Nutritional supplements for people being treated for active tuberculosis
Grobler, L., Nagpal, S., Sudarsanam, T. D., & Sinclair, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006086.pub4 · Cited by 281
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
The Treatment of Multidrug-Resistant Tuberculosis in Turkey
Tahaoğlu, K., Törün, T., Sevim, T., Ataç, G., Kir, A., Karasulu, L., Özmen, İ., & Kapaklı, N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450303 · Cited by 248
Yew, W. W., Chan, C. K., Chau, C. H., Tam, C. M., Leung, C. C., Wong, P. C., & Lee, J. (2000) · Chest · doi:10.1378/chest.117.3.744 · Cited by 231
Suárez, P. G., Floyd, K., Portocarrero, J., Alarcón, E., Rapiti, E., Ramos, G., Bonilla, C., Sabogal, I., Aranda, I., Dye, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08830-x · Cited by 211
Multidrug-Resistant Tuberculosis in Patients without HIV Infection
Telzak, E. E., Sepkowitz, K., Alpert, P., Mannheimer, S., Medard, F., El-Sadr, W., Blum, S., Gagliardi, A., Salomon, N., & Turett, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510053331404 · Cited by 208
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.1996.03540150031027 · Cited by 199
The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics.
Pablos-Méndez, A., Blustein, J., & Knirsch, C. A. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.4.574 · Cited by 189
Incidence of pulmonary tuberculosis among diabetics
Kim, S. J., Hong, Y. P., Lew, W. J., Yang, S. C., & Lee, E. G. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90529-4 · Cited by 181
Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study
Keshavjee, S., Gelmanova, I. Y., Farmer, P. E., Mishustin, S. P., Strelis, A. K., Andreev, Y. G., Pasechnikov, A. D., Atwood, S., Mukherjee, J. S., Rich, M. L., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61204-0 · Cited by 178
INCIDENCE OF POLARIZING FOREIGN BODIES IN LUNG BIOPSIES OF PATIENTS WITH PULMONARY SARCOIDOSIS
Sharma, V. K., Djekidel, K., Haber, M., & Haber, A. D. (2006) · Chest · doi:10.1378/chest.130.1.261 · Cited by 170
Multidrug-resistant and extensively drug-resistant tuberculosis: a review
Chan, E. D., & Iseman, M. D. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328319bce6 · Cited by 168
Suárez, Floyd, Portocarrero, & Alarcon (2002) · The Lancet · Cited by 166
Bashar, M., Alcabes, P., Rom, W. N., & Condos, R. (2001) · Chest · doi:10.1378/chest.120.5.1514 · Cited by 163
Multidrug-Resistant Tuberculosis in the New York State Prison System, 1990-1991
Valway, S. E., Greifinger, R. B., Papania, M., Kilburn, J. O., Woodley, C., DiFerdinando, G. T., & Dooley, S. W. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.1.151 · Cited by 160
Frieden, T. R., Sherman, L. F., Maw, K. L., Fujiwara, P. I., Crawford, J. T., Nivin, B., Sharp, V., Hewlett, D., Brudney, K. F., Alland, D., et al. (1996) · PubMed · Cited by 141
Multidrug-Resistant Tuberculosis
Sharma, S. K., & Mohan, A. (2006) · CHEST Journal · doi:10.1016/s0012-3692(15)50981-1 · Cited by 125
Tupasi, T. E., Gupta, R., Quelapio, M. I. D., Orillaza-Chi, R., Mira, N. R. C., Mangubat, N. V., Belen, V., Arnisto, N., Macalintal, L., Arabit, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030352 · Cited by 123
Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study
Chiang, C.-Y., Enarson, D. A., Yu, M.-C., Bai, K.-J., Huang, R.-M., Hsu, C.-J., Suo, J., & Lin, T.-P. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00125705 · Cited by 117
Cox, H. S., Kalon, S., Allamuratova, S., Sizaire, V., Nikolaevna, T. Z., Rüsch–Gerdes, S., Karimovich, H. A., Kebede, Y. N., & Mills, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001126 · Cited by 108
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin, S., Pasechnikov, A., Gelmanova, I. Y., Gg, P., Strelis, A. K., Mishustin, S. P., Barnashov, A., Karpeichik, Y., Andreev, Y. G., Vt, G., et al. (2006) · PubMed · Cited by 91
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Park, S. K., Lee, C. W., Lee, D. H., Mitnick, C. D., Han, L. L., & Seung, K. J. (2004) · PubMed · Cited by 76
Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
Granich, R. (2005) · JAMA · doi:10.1001/jama.293.22.2732 · Cited by 75
Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis
Mitnick, C. D., Castro, K. G., Harrington, M., Sacks, L. V., & Burman, W. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040292 · Cited by 71
Shean, K., Willcox, P. A., Siwendu, S., et al. (2008) · PubMed · Cited by 71
O'Riordan, P., Schwab, U., Logan, S. A. E., Cooke, G., Wilkinson, R. J., Davidson, R. N., Bassett, P., Wall, R. A., Pasvol, G., & Flanagan, K. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003173 · Cited by 66
Palmero, D., Ambroggi, M., Brea, A., De Lucas, M., Fulgenzi, A., Martínez, D., Mosca, C., Musella, R. M., Natiello, M., González, C. D., et al. (2004) · PubMed · Cited by 62
Treatment Experience of Multidrug-Resistant Tuberculosis in Florida, 1994–1997
Narita, M., Alonso, P. L., Lauzardo, M., Hollender, E. S., Pitchenik, A. E., & Ashkin, D. (2001) · CHEST Journal · doi:10.1378/chest.120.2.343 · Cited by 58
Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.
Masjedi, M. R., Tabarsi, P., Chitsaz, E., Baghaei, P., Mirsaeidi, M. S., Amiri, M., Farnia, P., Javanmard, P., Mansouri, D., & Velayati, A. A. (2008) · PubMed · Cited by 53
Outbreak of multidrug-resistant tuberculosis at a hospital--New York City, 1991.
(1993) · PubMed · Cited by 45
Nutritional supplements for people being treated for active tuberculosis
Abba, K., Sudarsanam, T. D., Grobler, L., & Volmink, J. A. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006086.pub2 · Cited by 39
Facing Extensively Drug-Resistant Tuberculosis — A Hope and a Challenge
Raviglione, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejme0804906 · Cited by 38
Multidrug-Resistant Tuberculosis: Long Term Follow-Up of 40 Non-HIV-Infected Patients
Avendaño, M. A., & Rs, G. (2000) · Canadian Respiratory Journal · doi:10.1155/2000/457905 · Cited by 35
Mathew, T. A., Yanov, S. A., Mazitov, R., Mishustin, S. P., Strelis, A. K., Yanova, G. V., Vt, G., Taran, D., Golubkov, A., Shields, A. L., et al. (2008) · European Journal of Public Health · doi:10.1093/eurpub/ckn093 · Cited by 30
Cited by
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Van Deun, A., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 647
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Gillespie, S. H., Crook, A. M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murray, S. R., Pappas, F., Phillips, P. P. J., & Nunn, A. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407426 · Cited by 645
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70139-0 · Cited by 574
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001300 · Cited by 535
Metadata
- Authors
- Johnston, J. C., Shahidi, N. C., Sadatsafavi, M., & Fitzgerald, J. M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-09
- Volume
- 4
- Issue
- 9
- Pages
- e6914
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2095281873
- Cited by
- 412
- References
- 44
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.